Objective: To measure and compare serum levels of leptin and lipid pro le parameters in primigravida women with PE and normotensive primigravida. Study Design: Analytical cross-sectional study. Place and Duration of Study: Department of Physiology and Cell Biology, University of Health Sciences, Lahore, from 2018 to 2020. Methodology: Preeclamptic (PE, group A) and normal primigravida (PG, group B) with gestational age 30-36 weeks were recruited from tertiary care hospitals. After written and informed consent, blood samples were taken. Serum was separated and stored at -80oC until processed. CBC and lipid pro le of each patient was also done using automated lab machines. Serum levels of leptin were calculated by ELISA. The data was entered and analysed in SPSS version 20. Results: The mean serum levels of leptin (ng/ml) in PE (group A) were signi cantly raised compared to normotensive PG (group B) at 33.44±12.91 and 4±6.20 respectively (p <0.001). The mean levels of TG (group A 242.40±73.96, group B 198±43.73, p = 0.003), LDL (group A 134.37±33.61, group B 115.70±22.32, p = 0.004), VLDL (group A 48.20±15.06, group B 39.52±8.79, p = 0.002), and cholesterol (group A 222.07±44.78, group B 290.77±86.89, p = 0.001), were signi cantly raised in patients of PE. The group A had signi cantly higher monocytes (5.90±5.9v4s). group B (3.35±0.94, p = 0.001) and platelets (group A, 230.25±73.27, vs. group B 290.77±86.89, p = 0.001). No correlation was found between leptin and other study parameters. Conclusion: Preeclamptic patients had signi cantly higher levels of leptin and hyperlipidemia independently. These ndings can be utilised for the early detection of disease.